CASOLI, Claudio
 Distribuzione geografica
Continente #
NA - Nord America 1.276
EU - Europa 1.002
AS - Asia 427
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 2
AF - Africa 1
Totale 2.713
Nazione #
US - Stati Uniti d'America 1.233
CN - Cina 378
UA - Ucraina 227
IE - Irlanda 216
SE - Svezia 197
FI - Finlandia 141
DE - Germania 103
CA - Canada 42
FR - Francia 39
TR - Turchia 38
GB - Regno Unito 35
IT - Italia 24
BE - Belgio 13
SG - Singapore 9
EU - Europa 5
AT - Austria 2
IN - India 2
NO - Norvegia 2
AU - Australia 1
ES - Italia 1
HR - Croazia 1
MA - Marocco 1
MX - Messico 1
NL - Olanda 1
NZ - Nuova Zelanda 1
Totale 2.713
Città #
Jacksonville 232
Dublin 216
Chandler 204
Beijing 108
Dearborn 95
Ann Arbor 82
Nanjing 69
Ashburn 57
Princeton 48
San Mateo 48
Izmir 37
Toronto 37
Wilmington 34
Boardman 26
Shanghai 24
Shenyang 22
Hebei 20
Woodbridge 20
Kunming 19
Los Angeles 18
Seattle 18
Hefei 17
Nanchang 16
Jinan 14
Brussels 13
Helsinki 12
New York 10
Tianjin 10
Changsha 9
Jiaxing 9
Norwalk 8
Auburn Hills 7
Guangzhou 6
Parma 6
Bremen 5
Hangzhou 4
Rockville 4
Taiyuan 4
Houston 3
Rome 3
Xian 3
Centuripe 2
Des Moines 2
Düsseldorf 2
Montréal 2
Ningbo 2
Oslo 2
Pune 2
Redwood City 2
Vienna 2
Zhengzhou 2
Bibbiano 1
Catania 1
Chengdu 1
Chongqing 1
Corner Brook 1
Edinburgh 1
Fremont 1
Fuzhou 1
Kocaeli 1
London 1
Mantova 1
Meda 1
Monmouth Junction 1
Odesa 1
Padova 1
Palma De Mallorca 1
Quzhou 1
Redmond 1
Santa Clara 1
Stockholm 1
Swift Current 1
Sydney 1
Wellington 1
Zagreb 1
Totale 1.641
Nome #
Biological insight into the mechanism of action of thiosemicarbazone complexes. 117
Copper(II) and Cobalt(III) Pyridoxal Thiosemicarbazone Complexes with Nitroprusside as Counterion: Syntheses, Electronic Properties, and Antileukemic Activity 99
The MHC class II transcriptional activator (CIITA) inhibits HTLV-2 viral replication by blocking the function of the viral transactivator Tax-2 91
THIOSEMICARBAZONES DERIVATIVES (TSCD) EFFECTS ON HIV, HTLV-1 AND HTLV-2 INFECTED CELLS 78
Striking changes of miRNAs expression in CD4+ T lymphocytes occurred even in the absence of an established HIV-1 infection. 75
Exposure of TF-1 cells to HTLV-II induces the activation of STAT1 and STAT5 through the secretion of IFN-g and GM-CSF 74
Antiretroviral Activity of Thiosemicarbazone Metal Complexes 70
HTLV-II infection exerts a protective role against AIDS progression in IDUs coinfected with HIV-1 69
Screening of HIV-1 Isolates By Reverse Heteroduplex Mobility Assay and Identification of Non-B Subtypes in Italy 67
HTLV-II influence on AIDS progression and changes in response to antiretroviral therapy in Italian IDUs coinfected with HIV-1 66
HIV e riproduzione umana 63
HTLV-II Downregulates HIV-1 replication in IL-2 Stimulated PBMC Cultures of Co-infected Individuals Through Expression of MIP-1a 63
A Naturally Occurring Antibody Fragment Neutralizes Infectivity of Diverse Infectious Agents 62
Anti-CD4-gp120 complex antibodies in long-term non-progressors HIV-1 positive patients: a role in slowing disease progression? 61
Un mimotopo sintetico killer, attivo nei confronti di patogeni opportunisti correlati ad AIDS inibisce l’infezione esogena ed endogena di HIV 59
Expression of cytokines and of chemokine receptors in PBMCs of HTLV-II mono-infected and HTLV-II/HIV-1 co-infected individuals 58
Azione concertata ELVIS: espressione selettiva della chemochina CCL3L1 in soggetti LTNP co-infettati da HIV-1 e HTLV-2 58
A killer mimotope with therapeutic activity against AIDS-related opportunistic microorganisms inhibits ex vivo HIV-1 replication 58
HTLV-II Replication inversely correlates with the expression of CIITA, the major regulator of HLA class II transcription 55
Negative interference of HTLV-II on HIV-1 replication via CC chemokines 55
Epidemiological and molecular data on 170 HTLV-2 cases of Italian IDUs 55
Human T-cell Leukemia virus type II (HTLV-II) induces STAT1 and STAT5 activation in CD34+ TF-1 cells 55
PBMC expression of cytokines and chemokine receptors in relation to AIDS progression and HTLV-II co-infection 54
HTLV-2 induces resistance to CCR5-dependent HIV-1 infection via selective PBMC expression of CCL3L1 54
Human T-cell leukemia virus type II induces survival and proliferation of CD34+ TF-1 cells via activation of STAT1 and STAT5 by secretion of Interferon-g and Granulocyte Macrophage-Colony Stimulating Facto 54
Up-regulation of the LD78b isoform of MIP-1a in PBMC cultures obtained from HTLV-2 infected/HIV-1 exposed seronegative individuals 54
Delayed progression to aids in HTLV-2/HIV-1 coinfected intravenous drug users 52
Retroviral cross-talk: HTLV-II Downregulates HIV-1 Replication from PBMC Cultures of Co-infected Individuals Via MIP-1a 52
HTLV-2 induces resistance to CCR5-dependent HIV-1 infection via selective PBMC expression of the CCL3/MIP-1alpha isoform L1/LD78beta 51
Selective CCL3L1/LD78b production by PBMCs during HTLV-2 infection induces resistance to HIV-1 entry 50
A dual defensive role of CIITA against retroviral infections 50
La coinfezione HIV-1/HTLV-II è associata ad un rallentamento della progressione AIDS 50
HTLV-2 influence on pathways regulating proliferation and death in B cell line BJAB 49
Serological and clinical follow-up of an Italian IVDU cohort of HTLV-II/HIV-1 co-infected patients. Evidence of direct relationship between CD4 count and HTLV-II proviral load 48
Specificity of the reverse Heteroduplex Mobility Assay (rHMA) for the identification of HIV-1 non-B clades in the new AIDS epidemic in Italy sustained by sexual transmission 48
The origin and evolution of Human T-cell Lymphotropic virus type II (HTLV-II) and the relationship with its replication 47
Post-genomic upregulation of CCL3L1 expression in HTLV-2 infected individuals curtails HIV-1 replication 47
The MHC class II transactivator: prey and hunter in infectious diseases 46
Dynamics of HIV viral load in blood and semen of patients under HAART: impact of therapy in assisted reproduction procedures 45
Post-genomic upregulation of CCL3L1 expression in HTLV-2 infected individuals curtails HIV-1 replication 45
Human T cell leukemia virus type II increases telomerase activity in uninfected CD34+ hematopoietic progenitor cells 43
Anti-CD4-GP120 complex antibodies in long term non progressors HIV-1 positive patients: a role in slowing disease progression?  43
Post-genomic upregulation of CCL3L1 expression in HTLV-2 infected individuals curtails HIV-1 replication 41
Coinfection with HIV-1 and human T-Cell lymphotropic virus type II in intravenous drug users is associated with delayed progression to AIDS 41
HTLV-II induces survival and proliferation of CD34+ TF-1 cells via activation of STAT1 and STAT5 by secretion of IFN-g and GM-CSF 40
The MHC Class II Transactivator (CIITA): a physiologic inhibitor of HTLV-2 retroviral infection 39
Inibizione della replicazione virale di HIV-1 e HTLV-2 da parte di CIITA, il regolatore trascrizionale dell’espressione dell’HLA-II 38
Inhibition of human T cell leucemia virus type 2 replication by the suppressive action of class II transactivator and nuclear factor Y 33
Totale 2.722
Categoria #
all - tutte 8.345
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.345


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201953 0 0 0 0 0 0 0 0 0 0 53 0
2019/2020733 126 131 56 6 64 82 80 9 57 50 21 51
2020/2021388 6 55 51 3 55 4 48 4 91 11 56 4
2021/2022250 3 8 1 9 18 1 35 48 7 19 45 56
2022/2023786 92 96 51 63 66 70 12 37 262 4 22 11
2023/2024197 22 33 2 4 28 49 18 23 12 6 0 0
Totale 2.722